Chemoinformaics analysis of Piperidinylbenzopyranone
| Molecular Weight | 229.279 | nRot | 1 |
| Heavy Atom Molecular Weight | 214.159 | nRig | 11 |
| Exact Molecular Weight | 229.11 | nRing | 3 |
| Solubility: LogS | -1.039 | nHRing | 2 |
| Solubility: LogP | 0.786 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 36.0859 |
| nHD | 0 | BPOL | 19.3621 |
| QED | 0.604 |
| Synth | 3.489 |
| Natural Product Likeliness | 0.878 |
| NR-PPAR-gamma | 0.844 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.264 |
| HIA | 0.006 |
| CACO-2 | -4.688 |
| MDCK | 0.000021 |
| BBB | 0.182 |
| PPB | 0.558122 |
| VDSS | 0.765 |
| FU | 0.535264 |
| CYP1A2-inh | 0.06 |
| CYP1A2-sub | 0.538 |
| CYP2c19-inh | 0.045 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.051 |
| CYP2c9-sub | 0.858 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.75 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.226 |
| CL | 13.109 |
| T12 | 0.908 |
| hERG | 0.011 |
| Ames | 0.682 |
| ROA | 0.179 |
| SkinSen | 0.267 |
| Carcinogencity | 0.452 |
| EI | 0.095 |
| Respiratory | 0.878 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.720061 |